BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Diagnostic Industry Veteran, Jim LaFrance, Joins the LightIntegra Technology Board of Directors

  LightIntegra Technology announced today that Jim LaFrance has been appointed to its Board of Directors.

  February 6, 2018

   · 

  2 min read
• Business

  Selvita Appoints Steffen Heeger, M.D., PhD as CMO

  Dr. Heeger will join Selvita in February and will be responsible for all clinical, medical affairs and regulatory functions for Selvita oncology pipeline including SEL24.

  February 6, 2018

   · 

  2 min read
• Cynata Engineered MSC Study Interim Data Review Reveals Promising Results

  Cynata is pleased to announce that the first stage of its ongoing study evaluating the ability to genetically engineer Cymerus mesenchymal stem cells for the potential treatment of certain cancers has been completed, with very promising results.

  February 6, 2018

   · 

  3 min read
• Drug Development

  BriaCell Opens Fourth Clinical Site in Advanced Breast Cancer

  The company’s CRO will manage the clinical and regulatory aspects of the clinical trial on behalf of BriaCell.

  February 6, 2018

   · 

  6 min read
• Pharm Country

  Creative BioMart Released Non-Animal Skin Sensitization Testing Services

  Three non-animal assays formally validated and regulatory adopted including DPRA, the KeratinoSens assay and the human cell line activation test are introduced to assist non-animal skin sensitization testing.

  February 6, 2018

   · 

  1 min read
• Business

  Mr. David Ben Naim, CPA, MBA Joins Todos Medical as CFO

  Mr. Ben Naim has a distinguished record as Chief Financial Officer for companies listed in both the United States and Israel.

  February 6, 2018

   · 

  4 min read
• Genetown

  FDNA Grants Manchester Centre for Genomic Medicine at Saint Mary’s Hospital, UK as Center of Research Excellence; Advancing Next-Generation Phenotyping for Genetics Evaluations

  The grant provides funding to researchers to advance next-generation phenotyping (NGP) and facial analysis technology at luminary sites working on precision medicine.

  February 6, 2018

   · 

  3 min read
• Policy

  Cellenkos Announces FDA Registration of GMP Manufacturing Facility

  Cellenkos manufacturing facility manufactures cord blood-derived Regulatory T cell therapeutics.

  February 6, 2018

   · 

  2 min read
• Business

  Applied DNA and TheraCann International Conduct Successful Tagging and Testing Pilot of Legal Cannabis and Derivative-Products

  Applied DNA announced today that in conjunction with TheraCann International Benchmark Corporation, it has had early success in the tagging and authentication of legal cannabis and its derivatives in a laboratory pilot.

  February 6, 2018

   · 

  5 min read
• Business

  Haemonetics 3rd Quarter Fiscal 2018 Earnings Release Available on Investor Relations Website

  Haemonetics announced that third quarter and year-to-date fiscal 2018 financial results are available on its Investor relations website.

  February 6, 2018

   · 

  1 min read